REFERENCES
- Boesen P, Sørensen S F. Giant cell arteritis, temporal arteritis, and polymyalgia rheumatica in a Danish county. A prospective investigation, 1982–1985. Arthritis Rheum 1987; 30: 294–299
- Weyand C M, Kaiser M, Yang H, et al. Therapeutic effects of acetylsalicylic acid in giant cell arteritis. Arthritis Rheum 2002; 46: 457–466
- Nesher G, Berkun Y, Mates M, et al. Low-dose aspirin and prevention of cranial ischemic complications in giant cell arteritis. Arthritis Rheum 2004; 50: 1332–1337
- Lee M S, Smith S D, Galor A, et al. Antiplatelet and anticoagulant therapy in patients with giant cell arteritis. Arthritis Rheum 2006; 54: 3306–3309
- Hellman D B. Low dose aspirin in the treatment of giant cell arteritis. Arthritis Rheum 2004; 50: 1026–1027
- Spiera R F, Spiera H. Therapy for giant cell arteritis: Can we do better?. Arthritis Rheum 2006; 54: 3071–3074
- Warrington K J, Matteson E L. Management guidelines and outcome measures in giant cell arteritis (GCA). Clin Exp Rheumatol 2007; 25(Suppl. 47)S137–S141